¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀå º¸°í¼­ : Á¦Ç°, ¿¬·ÉÃþ, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)
Smart Syringe Market Report by Product, Age Group, Application, End User (Hospitals and HMOs, Diabetic Patients, Family Practices, Psychiatrics, and Others), and Region 2024-2032
»óǰÄÚµå : 1541134
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 138 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,339,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,786,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,233,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀå ±Ô¸ð´Â 2023³â 95¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC ±×·ìÀº ½ÃÀåÀÌ 2032³â±îÁö 173¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, 2024³â°ú 2032³â »çÀÌ¿¡ 6.63%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

½º¸¶Æ® ÁÖ»ç±â´Â Àç»ç¿ëÀ» ¹æÁöÇÏ°í ¾ÈÀüÇÏÁö ¾ÊÀº ÁÖ»ç ¹æ¹ýÀ» ±ÔÁ¦ÇÏ´Â ¾ÈÀü ¸ÞÄ¿´ÏÁòÀ» °®Ãá ÀÇ·á±â±âÀÔ´Ï´Ù. ÇÁ¸®¼Â ÆÄ¶ó¹ÌÅÍ, »ç¿ë ¹üÀ§, »ç¿ë »óȲ ÃßÀû ±â´ÉÀ» °®Ãá Àбâ/¾²±â ĨÀÌ ³»ÀåµÇ¾î ÀÖ½À´Ï´Ù. ÀÚµ¿ ºñȰ¼ºÈ­(AD), ¼öµ¿ ¾ÈÀü ¹× Ȱ¼º ¾ÈÀü ÁÖ»ç±âÀÇ º¯ÇüÀÌ ÀϹÝÀûÀÔ´Ï´Ù. Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º(HIV), AÇü °£¿°, BÇü °£¿°, ´ç´¢º´ µî ½É°¢ÇÑ Áúȯ°ú Áõ»óÀ» °¡Áø ȯÀÚÀÇ Ä¡·á¿¡ µµ¿òÀÌ µË´Ï´Ù. ¿¹¹æ Á¢Á¾, ¾à¹° Àü´Þ, Ç÷¾× ½Ã·á äÃë µî¿¡ »ç¿ëµË´Ï´Ù. ±× °á°ú ¼¼°èÀÇ º´¿ø, Áø·á¼Ò, Áø´Ü¼Ò, ¿¹¹æ Á¢Á¾ ¼¾ÅÍ¿¡¼­ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù.

½º¸¶Æ® ÁÖ»ç±â ½ÃÀå µ¿Çâ :

´ëÁßµé »çÀÌ¿¡¼­ ¸¸¼º Áúȯ°ú ¹ÙÀÌ·¯½º °¨¿°ÀÇ À¯ÇàÀÌ Áõ°¡ÇÏ´Â °ÍÀº ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ½É°¢ÇÑ ÀÇ·á Áúȯ¿¡ °É¸®±â ½¬¿î °í·ÉÈ­ Àα¸ Áõ°¡¿¡µµ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ´ëÁßµé »çÀÌ¿¡¼­ Ç÷¾×À» ¸Å°³·Î ÇÏ´Â °¨¿°ÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÚ°¡ÁÖ»çÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î ħħ »ç°í¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö°í ¾ÈÀüÇÑ ÁÖ»ç¹ý¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ ¾÷°è¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ´ë±â¾÷¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. °Ô´Ù°¡, Ãâ»ý¼öÀÇ È®´ë¿Í û¼Ò³â »çÀÌ¿¡¼­ ´Ù¾çÇÑ ¼Ò¾Æ ÁúȯÀÇ À¯º´·üÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ, ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦Ç° Á¦Á¶¾÷ü´Â °£´ÜÇÑ ¸ð´ÏÅ͸µÀ» À§ÇØ ÅÍÄ¡ ½ºÅ©¸° ¹× Wi-Fi ȣȯ ¼ÒÇü ¹× Æí¸®ÇÑ °æ·® ¼Ö·ç¼ÇÀ» µµÀÔÇß½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÀÇ·á ÀÎÇÁ¶ó ¹× ÀÇ·á ¼­ºñ½º °³¼±¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ±¤¹üÀ§ÇÑ Á¶»ç °³¹ß(R&D) Ȱµ¿ÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦7Àå ½ÃÀå ºÐ¼® : ¿¬·ÉÃþº°

Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global smart syringe market size reached US$ 9.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.63% during 2024-2032.

A smart syringe is a medical device engineered with safety mechanisms to prevent reuse and regulate unsafe injection practices. It is incorporated with a read and write chip with preset parameters, ranges, and usage tracking. It is commonly available in variants of auto-disable (AD), passive safety, and active safety syringes. It aids in treating patients with critical disorders and conditions, such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and diabetes. It is used for vaccination, drug delivery, and blood specimen collection. As a result, it is utilized in hospitals, clinics, diagnostics, and vaccination centers across the globe.

Smart Syringe Market Trends:

The increasing prevalence of chronic diseases and viral infections among the masses represents one of the major factors positively influencing the demand for smart syringes around the world. It can also be attributed to the growing aging population, which is more prone to severe medical diseases. Moreover, the expanding number of blood-borne infections among the masses is favoring the market growth. In addition, the rising demand for self-injecting medicines is contributing to the market growth. Apart from this, increasing concerns about needle stick injuries and the rising awareness about safe injection practices are offering lucrative growth opportunities to leading players operating in the industry. Furthermore, the expanding number of births and the growing prevalence of various pediatric diseases among adolescents are creating a positive outlook for the market. Additionally, product manufacturers are introducing small-sized, convenient, lightweight with touch screens and Wi-Fi-enabled solutions for easy monitoring. Besides this, rising investments in improving healthcare infrastructure and medical services and extensive research and development (R&D) activities are expected to propel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global smart syringe market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, age group, application and end user.

Breakup by Product:

Auto-disable Syringes

Active Safety Syringes

Passive Safety Syringes

Breakup by Age Group:

Pediatrics

Adults

Breakup by Application:

Drug Delivery

Vaccination

Blood Specimen Collection

Breakup by End User:

Hospitals and HMOs

Diabetic Patients

Family Practices (Physicians)

Psychiatrics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AdvaCare Pharma, B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, Merit Medical Systems Inc., Nipro Corporation, Numedico Technologies Pty Ltd., Retractable Technologies Inc. and Terumo Corporation.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Smart Syringe Market

6 Market Breakup by Product

7 Market Breakup by Age Group

8 Market Breakup by Application

9 Market Breakup by End User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â